2,6-dimethylpyridin-3-amine | CAS:3430-33-9

We serve 2,6-dimethylpyridin-3-amine CAS:3430-33-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,6-dimethylpyridin-3-amine

Chemical Name:2,6-dimethylpyridin-3-amine
CAS.NO:3430-33-9
Synonyms:2,6-dimethylpyridin-3-amine
2,6-Dimethyl-3-pyridylamine
3-AMINO-2,6-DIMETHYLPYRIDINE
2,6-dimethyl-pyridin-3-ylamine
Molecular Formula:C7H10N2
Molecular Weight:122.16800
 
Physical and Chemical Properties:
Density:1.039
Melting point:121-123ºC
Boiling point:230ºC
Flash point:230ºC
Index of Refraction:1.564
 
Specification:
Appearance:Yellow powder
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2,6-dimethylpyridin-3-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-dimethyl-pyridin-3-ylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-AMINO-2,6-DIMETHYLPYRIDINE Use and application,3-AMINO-2,6-DIMETHYLPYRIDINE technical grade,usp/ep/jp grade.


Related News: This includes chemical APIs.methyl 2-bromo-3-[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]propanoate manufacturer This includes chemical APIs.3-Amino-1,2-propanediol supplier Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.Sulfur dichloride vendor Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.